Adam Raymakers
Impact in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Lung Cancer Diagnosis and Treatment
- Gallbladder and Bile Duct Disorders
- Respiratory Support and Mechanisms
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 11
- Pharmaceutical Economics and Policy 4
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
- Lung Cancer Diagnosis and Treatment 4
- Co-authors
- Carlo A. Marra (7 shared papers)Fawziah Marra (2 shared papers)Larry D. Lynd (7 shared papers)Mohsen Sadatsafavi (3 shared papers)Stuart Peacock (8 shared papers)Dean A. Regier (9 shared papers)Don D. Sin (4 shared papers)Paddy Gillespie (6 shared papers)
- Journals
- Journal of Cancer Policy (4 papers)Health Policy and Technology (3 papers)Respirology (2 papers)Value in Health (2 papers)JAMA (2 papers)
- Partner nations
- CanadaUnited StatesIreland
In The Last Decade
Adam Raymakers
43 papers receiving 674 citations
Peers
Comparison fields: 5 of 92
- Pulmonary and Respiratory Medicine 188
- Geriatrics and Gerontology 18
- Oncology 120
- Epidemiology 120
- Internal Medicine 10
Countries citing papers authored by Adam Raymakers
This map shows the geographic impact of Adam Raymakers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Raymakers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Raymakers more than expected).
Fields of papers citing papers by Adam Raymakers
This network shows the impact of papers produced by Adam Raymakers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Raymakers. The network helps show where Adam Raymakers may publish in the future.
Co-authors
The 25 scholars most cited alongside Adam Raymakers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 76 | |
| 2 | 2012 | 74 | |
| 3 | 2017 | 55 | |
| 4 | 2016 | 50 | |
| 5 | 2012 | 44 | |
| 6 | 2017 | 39 | |
| 7 | 2011 | 36 | |
| 8 | 2019 | 35 | |
| 9 | 2023 | 29 | |
| 10 | 2016 | 26 | |
| 11 | 2017 | 22 | |
| 12 | 2017 | 22 | |
| 13 | 2020 | 20 | |
| 14 | 2018 | 18 | |
| 15 | 2019 | 16 | |
| 16 | 2013 | 16 | |
| 17 | 2022 | 11 | |
| 18 | 2021 | 10 | |
| 19 | 2019 | 9 | |
| 20 | 2019 | 8 |
About Adam Raymakers
Adam Raymakers is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine, General Health Professions, Oncology and Pathology and Forensic Medicine, having authored 47 papers that have together received 695 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Pharmaceutical Economics and Policy (4 papers), CAR-T cell therapy research (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Global Health Care Issues (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Healthcare cost, quality, practices (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (188 citations), Geriatrics and Gerontology (18 citations), Oncology (120 citations), Epidemiology (120 citations) and Internal Medicine (10 citations). Adam Raymakers has collaborated with scholars based in Canada, United States and Ireland. Frequent co-authors include Carlo A. Marra, Fawziah Marra, Larry D. Lynd, Mohsen Sadatsafavi, Stuart Peacock, Dean A. Regier, Don D. Sin, Paddy Gillespie, Sam M. Wiseman and Aaron S. Kesselheim. Their work appears in journals such as Journal of Cancer Policy, Health Policy and Technology, Respirology, Value in Health and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.